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Sleep and breathing disorders are highly prevalent, 
representing a growing subspecialty of respiratory 
medicine. The term sleep disordered breathing (SDB) 
encompasses a range of conditions characterised 
by abnormal breathing during sleep, from chronic 
or habitual snoring, to frank obstructive sleep 
apnoea (OSA) or, in some cases, central sleep 
apnoea (CSA) and hypoventilation syndromes. 
OSA is the commonest form of SDB, leading to 
many potential consequences and adverse clinical 
outcomes, including excessive daytime sleepiness, 
impaired daytime function, metabolic dysfunction, 
and an increased risk of cardiovascular disease and 
mortality [1]. The estimated reported prevalence 
of moderate-to-severe SDB (≥15 events·h−1) was 
23.4% in women and 49.7% in men, and the 
prevalence of symptomatic OSA was 9% and 13%, 
respectively [2]. However, in some populations, 
the prevalence of OSA is substantially higher, such 
as in patients been evaluated for bariatric surgery 
(estimated range 70–80%), in patients who have 
had a transient ischaemic attack or stroke (estimated 
range 60–70%) and in patients with cardiometabolic 
disease [3–6]. Limited data have been reported 
on CSA and non-obstructive sleep-related 
hypoventilation, which have received considerable 
interest in the sleep field within the past 10 years. 
Even if their prevalence was noted to be quite low 
relative to the prevalence of OSA [7], they are quite 
common in specific subpopulations [8–10].
Unquestionably, considerable progress has been 
made in past decades regarding basic science, 
and technical, clinical and therapeutic aspects of 
SDB. Furthermore, as sleep is essential for general 
health, SDB is important for general health as well. 
The field is still evolving and additional research 
to improve the diagnostic accuracy of simplified 
screening tools is needed to ensure that patients 
with SDB are accurately identified. However, 
the task of routine screening, assessment and 
management of SDB is particularly challenging. 
Inconsistencies in the diagnosis and management 
of SDB emphasise the need for standards in practice 
with special knowledge and expertise for medical 
practitioners managing respiratory sleep patients 
[11]. Moreover, in an era of evolving precision 
medicine, personalising therapeutic applications 
should be established on patient individualisation, 
correctly identifying their clinical profile and needs.
The respiratory sleep 
medicine project
Assembly 4 of the European Respiratory Society 
(ERS) is in the unique position of designing and 
delivering educational activities, such as successful 
symposia at the annual International ERS Congress, 
including Meet the Expert and Postgraduate Courses, 
research and education projects, Task Forces, 
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Statements, Guidelines, research seminars and 
awards, which raise the standards of training for 
our respiratory health practitioners. Group 4.02, 
the largest in Assembly 4, provides a forum where 
scientists and clinicians interested in the causes 
and consequences of SDB can meet and share their 
ideas. By organising a specific Task Force, the Group 
has focused its activities on raising the awareness 
of sleep and breathing problems at the level of the 
European Commission and promoted identification 
of sleep-related disorders as a major priority in 
European Union health policies. Specifically, the 
Task Force produced Guidelines on non-continuous 
positive airway pressure (CPAP) therapies for 
obstructive sleep apnoea and Statements on the 
definition, discrimination, diagnosis and treatment 
of central breathing disturbances during sleep [12, 
13]. Furthermore, upcoming statements are on 
the effectiveness of CPAP treatment on OSA in 
commercial and non-commercial motor vehicle 
drivers and new diagnostic techniques. Once 
published, the documents will provide clarity and 
direction for a number of topics in respiratory 
medicine with the aim of improving clinical practice. 
Moreover, the continuing educational interest of 
the ERS is shown by the number of issues of the 
ERS Monograph published in the past 20 years. 
The ERS Monograph is a quarterly book series 
covering a specific area of respiratory medicine 
and providing up-to-date and in-depth reviews that 
give clinicians a concise, comprehensive guide to 
symptoms, diagnosis and treatment. Group 4.02 
also carries out educational and scientific activities 
in collaboration with the European Sleep Research 
Society (ESRS). In this direction, a collaborative 
European network project, the European Sleep 
Apnoea Database cohort, was established in 2007 
with the objective to recruit a large prospective 
international cohort of patients with OSA for cross-
sectional and outcome research and to serve as 
a bridge for education and knowledge transfer 
between the various participating centres [14].
The ERS, in collaboration with the ESRS, 
established the biannual Sleep and Breathing 
Conference. The ESRS initiated an examination 
in sleep medicine at the 2012 ESRS Congress in 
Paris, France, leading to “somnologist” certification, 
followed by a second examination held during the 
2013 Sleep and Breathing Conference in Berlin, 
Germany. So far, over 600 physicians, psychologists 
and sleep scientists across Europe have obtained 
this certificate. The certification confirms successful 
education and training in sleep medicine, including 
clinical scientific knowledge and technical skills 
and, therefore, proof of competence in the field of 
sleep medicine. Although National Sleep Societies 
(NSSs) have not adopted this qualification, many 
provide a certificate in sleep medicine in accordance 
with local customs or regulations. However, the 
Assembly of NSS and the ESRS Sleep Medicine 
Committee are in the process of identifying 
strategies to endorse this qualification, in order to 
achieve a homogenous standard of practice across 
Europe. The ESRS has also produced a catalogue of 
knowledge and skills as a basis for sleep medicine 
education and a multi-author textbook on sleep 
medicine, based on this catalogue, which was 
finalised in 2014. The ESRS is in the progress of 
updating this edition. Together the ERS and ESRS 
could significantly enhance the quality of each 
project with the objective to improve the quality 
of care for patients throughout Europe who suffer 
from these disorders.
Periodical revisiting of the 
ERS curriculum development: 
future directions
As no harmonised standards of training exist across 
Europe for respiratory sleep medicine, the ERS 
supported an application for a Sleep Harmonised 
Education in Respiratory Medicine for European 
Specialists (HERMES) Task Force project [15]. The 
HERMES Sleep Task Force and project were officially 
launched during the 2009 ERS International 
Congress in Vienna (Austria). The European core 
syllabus in respiratory disorders during sleep was 
published in 2011, followed by the production of 
educational materials including the ERS Handbook 
of Respiratory Sleep Medicine [16] and the respiratory 
sleep medicine curriculum in 2015. The ERS 
curriculum (formerly known as HERMES) was 
developed to present a common curriculum for 
medical and allied-health professionals, as well as 
to support teaching and certification in respiratory 
sleep medicine. The first course of the respiratory 
sleep certified training programme, initiated by the 
ERS Sleep Training Committee, took place during 
the 2017 Sleep and Breathing Conference(Marseille, 
France), followed by a second course held during the 
2019 Sleep and Breathing Conference (Marseille), 
which was well attended. The aim of this course 
was to train respiratory professionals at a post 
specialty or postgraduate level in respiratory sleep 
medicine. The programme includes two parts with 
five independent modules and, following successful 
completion, a respiratory sleep certified training 
programme certificate is obtained. The programme 
overview can be viewed on the ERS website (www.
e r s n e t . o r g / p r o f e s s i o n a l - d e v e l o p m e n t /
respiratory-sleep-certified-training-programme).
Over the years, the process of curriculum 
design has been improved within the ERS and it 
will continue to evolve, including more e-learning 
videos and CME online modules. There is also an 
updated edition of the ERS Handbook of Respiratory 
Sleep Medicine in planning. The sleep and 
breathing continuous professional development 
catalogue will be used as the contextual basis 
of our educational programme. This recently 
developed catalogue covers the SDB trajectory in 
23 modules, as shown in table 1. Each module 
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Table 1 Module-based continuous professional development training
Module 1: Neuroanatomy and neurobiology of sleep
Regulation of sleep–wake cycle
Recognise basic neural processes and transmitters controlling wakefulness, non-rapid eye movement 
and rapid eye movement sleep states
Describe sleep architecture in a normal adult
Understand how the ageing process from fetal life to old age affects the sleep cycle
Sleep as a biologic process essential for life and optimal health
Module 2: Physiology of sleep and breathing
Control of breathing: explain factors that control breathing during sleep and wakefulness
Understand ventilatory response to hypercapnia, and hypoxaemia (including loop gain), arousal and 
apnoea threshold
Describe the functional anatomy of the upper airway
Discuss the factors that cause upper airway collapse during sleep
Relate control of breathing and upper airway function to the pathophysiology of obstructive sleep 
apnoea and central sleep apnoea
State how respiratory mechanics and ventilation are influenced by pathology
Explain sleep-related changes in respiratory mechanics in the aetiology of nocturnal hypoventilation
Module 3: Cardiovascular and homeostatic mechanisms and sleep
Understand how cardiovascular function, e.g. blood pressure and heart rate is affected during sleep 
and arousal from sleep
Appreciate impact of sleep on autonomic regulation and the consequences of sleep pathology. e.g. in 
OSA and CSA
Module 4: Physiology of arterial blood gas and acid-base status
The utility of arterial blood gas, capillary blood gas and venous blood gas
Diagnosis of A-B disorders: Henderson–Hasselbach equation, the relationship of oxygen tension, 
carbon dioxide tension and pH
A-B disorders: the importance D(A-a) difference, inspiratory oxygen fraction, alveolar gas equation and 
measuring oxygen shunts
Module 5: Define SDB
OSAHS, CSA, periodic breathing, Cheyne–Stokes respiration, obesity hypoventilation syndrome, 
nocturnal hypoventilation, upper airways resistance syndrome
Describe the epidemiology of OSAHS and CSA
Describe the different clinical phenotypes of OSA and their relationship to underlying pathophysiology
Module 6: Assessment of the patient








Low mood or labile mood
Cognitive impairment
(Continued)
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Table 1 Continued Module-based continuous professional development training
Signs:




Assess for comorbidities, e.g. COPD, chest wall disease, neuromuscular or neurological disorder, 
cardiovascular disease, endocrine or metabolic disorder
Module 7: Evaluate impact of symptoms and establish pre-test probability of SDB
Use of questionnaires: Epworth Sleepiness Scale, STOP-BANG score, Berlin questionnaire, 36-Item 
Short Form Health Survey, insomnia evaluation
Identify high-risk patients, e.g. severe sleepiness, unstable cardiac disease, nocturnal arrhythmia, 
baseline hypoxaemia, driving or other occupational risk
Module 8: Diagnosis of respiratory sleep disorder
Recognise the methodology of the different sleep tests (oximetry, respiratory polygraphy, full 
polysomnography)
Understand limitations of overnight oximetry, respiratory polygraphy and polysomnography, and 
home versus hospital-based sleep studies
Appreciate which patients to refer for polysomnography, e.g. those in whom diagnosis unclear on 
respiratory polygraphy, or poor treatment response or if non-respiratory sleep disorder suspected, 
e.g. narcolepsy, restless leg syndrome
Identify cases where further specialised examinations are needed, e.g. ear, nose and throat review of 
upper airway
Review cardiovascular, respiratory and metabolic disorders often associated with OSA
Clearly explain the high cardiometabolic risks associated with untreated OSA
Discuss the value of making improvements to lifestyle including weight loss, adherence to drug 
treatment for hypertension or diabetes, smoking cessation, alcohol reduction, physical exercise
Module 9: Nocturnal capnography
Role of capnography in patients with nocturnal hypoventilation
Understand limitations of overnight transcutaneous total carbon dioxide and end-tidal carbon dioxide 
tension monitoring
Appreciate use of capnography to establish ventilator settings
Module 10: OSAHS management
Distinguish mild, moderate and severe cases of OSA from normal results and upper airway resistance 
syndrome
Explain lifestyle interventions including weight loss, physical activity, exercise training, smoking 
cessation, alcohol reduction, avoidance of night sedation, sensible sleep hygiene measures
Understand role of ear, nose and throat intervention
Understand role and types of mandibular advancement splint or other oral device
Understand definition of positional sleep apnoea and role of positional devices
Appreciate indications for CPAP therapy
Understand differences between fixed level CPAP, variable CPAP and bi-level positive pressure therapy
Depending on local pathways appreciate which patients to refer for these interventions
Understand CPAP related side-effects such as interface problems, airway drying, sleep disturbance
Appreciate issues leading to poor adherence and how these may be addressed
Understand different ways of monitoring positive pressure therapy: clinic visits, data downloads from 
devices, telemonitoring
(Continued)
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Table 1 Continued Module-based continuous professional development training
Appreciate follow-up involves assessment of efficacy of therapy in controlling OSA but also impact on 
comorbidities and health-related quality of life
Importance of explaining rationale of treatment and likely outcomes to patient and advise on medico 
legal aspects, such as driving
Pre-peri and post-operative assessment and management of patients with OSAHS
Be aware of and follow local guidelines on diagnosis and management of OSAHS
Module 11: CSA
Classify aetiology of CSA: idiopathic, due to heart failure, cerebrovascular cause, e.g. cerebrovascular 
accident, opioid or other drug use, altitude
Differential symptoms and signs of OSA and CSA
Understand the pathophysiology of different types of CSA
Recognise which patients to refer for sleep studies
Module 12: Management of CSA
Understand impact of CSA on underlying pathology
CSA in chronic heart failure:
Appreciate importance of optimising therapy for heart failure
Understand role of CPAP in some patients including those with mixed OSA and CSA
Understand that ASV should not be used in heart failure patients with left ventricular ejection fraction <45%
Other forms of CSA:
Understand that CPAP or ASV may be of value in opioid-induced SDB
Appreciate further trials in progress assessing oxygen therapy in CSA and further role of ASV
Module 13: Obesity hypoventilation syndrome
Recognise symptoms, clinical presentation, and pathophysiology of obesity hypoventilation
Explain consequences (vascular disease, polycythaemia, cor pulmonale)
Assess indications for CPAP, NIV, application or supervision of mask and interface
Explain condition and the risks of obesity, and offer advice on how to decrease body mass index 
through physical activity, training and diet
Understand role of bariatric surgery, pre-operative assessment surgical risk, and peri-/post-operative 
management in OHS patients
Module 14: Neuromuscular disorders
Understand neuromuscular diseases causing respiratory failure
Neuromuscular conditions associated with respiratory muscle weakness
Appreciate methods to assess respiratory muscles weakness: spirometry, mouth pressures, peak 
cough flow, sniff inspiratory pressure, diaphragm EMG studies
Symptoms and signs of nocturnal hypoventilation and the probability of respiratory failure
Role of NIV versus invasive ventilation
Cough augmentation (cough assist) techniques
Use of NIV
Peri-operative assessment and management of neuromuscular disease patients
Module 15: Chest wall disorder
Recognise chest wall deformities causing respiratory failure, e.g. scoliosis, thoracoplasty
Symptoms and signs of nocturnal hypoventilation and the probability of respiratory failure, indications 
for sleep study
Role of NIV versus invasive ventilation, and cough augmentation (cough assist) techniques
Use of NIV
(Continued)
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Table 1 Continued Module-based continuous professional development training
Module 16: Chronic respiratory failure
Causes of respiratory failure
Principles of interpretation of blood gas analysis
National and international guidelines for treatment of acute and chronic hypercapnic respiratory failure
Indications of additional oxygen treatment
Indications for long-term (home) mechanical ventilation in COPD, neuromuscular disease, chest wall 
disorders
Module 17: Assisted ventilation
Treatment of ventilatory failure
Describe types of positive pressure ventilation and different modes, e.g. bi-level positive airway 
pressure, volume ventilation, assured volume ventilation (AVAPS, iVAPS) ventilation, and other NIV 
modes; appreciate types of interface
Understand principles of titration of therapy with sleep studies and arterial blood gas measurement
Recognise the concepts of compliance and adherence
Assessment of compliance and reasons for poor and good compliance
Understand indications for tracheostomy ventilation and who to refer for this
Understand NIV may have a palliative role, and importance of palliative therapy
Use of advance directives in end-stage diseases
Module 18: Asthma/COPD and sleep
Prevalence of SDB in asthma and COPD
Appraise symptoms, clinical presentation, pathophysiology and treatment of asthma, COPD
Relate the influence of comorbid respiratory disorders on breathing during sleep
Appreciate impact of drug therapy on sleep quality
Understand role of CPAP therapy in overlap syndrome (COPD+OSAHS) and asthma
Module 19: Endocrine and metabolic disorders and SDB
Appreciate increased prevalence of OSAHS in endocrine disorders (e.g. hypothyroidism), acromegaly 
metabolic disorders (e.g. diabetes mellitus, metabolic syndrome and renal failure)
Understand impact of treatment of OSAHS on underlying endocrine/metabolic disorder
Module 20: Non-respiratory sleep disorders
Consider presence of non-respiratory sleep disorders and referral for sleep specialist assessment
Insomnia:
Recognise primary and secondary insomnia, management techniques including role of cognitive 
behavioural therapy and medication
Recognise presence of insomnia in some OSAHS phenotypes and its impact on implementation and 
adherence with therapy, e.g. CPAP
Other conditions to be aware of include restless leg syndrome
Narcolepsy, benign idiopathic hypersomnolence, parasomnias and associated conditions
Recognise which patients to refer for further investigation
Module 21: Assessment of excessive sleepiness
Understand the principles of sleep questionnaires, sleep diary, Multiple Sleep Latency Test, Maintenance 
of Wakefulness Test, Osler wake test in assessing excessive daytime somnolence in respiratory and 
non-respiratory sleep conditions, their advantages, imitations, and who to refer for these
Module 22: Circadian disorders
Understand principles of circadian rhythm and impact on sleep wake cycle across age range
Appreciate impact of circadian disruption such as shift work and jet lag
(Continued)
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will be maintained and regularly updated according 
to future developments by a faculty composed not 
only of senior scientific specialists in SDB, but also 
of committed Early Career Members since they 
represent our future. Digital and social media 
might be used to deliver the message and the 
education itself, utilising the already available ERS 
communication channels.
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